Aspero Medical was selected to present at AGA's Tech Summit Shark Tank competition and was voted People's Choice Award winner for presenting the Ancora platform that is designed to revolutionize third space endoscopy with simple, practical devices that create greater access, stabilization, and retraction with exceptional ease of use.

Aspero Medical has received clearance from the FDA to market and sell the Ancora-SB small bowel balloon overtube that incorporates the company’s patented Pillar micro-texture balloon technology. Ancora-SB is cleared for use during small bowel enteroscopy procedures.

Aspero Medical's advanced intraoperative C-Tube is an innovative technology designed to enable more efficient and effective colonoscopies. 

Aspero Medical selected as one of 10 innovative startups to pitch at the 2021 Angel Capital Summit presented by Rockies Venture Club.

Spinout company of CU Boulder’s Paul M. Rady Department of Mechanical Engineering awarded $225,000 through the NSF SBIR program.

Innosphere Fund Invests in University of Colorado Boulder Medical Device Startup Company.

Boulder, Colorado based startup company expands team to include Allison Lyle (Director of Engineering) and Jeff Castleberry (Director of Operations) to support company's next generation medical devices.

Destination Startup is a collaboration among leading research universities and federal laboratories across the Rocky Mountain region to showcase the best companies from our innovation ecosystem. 

Aspero Medical awarded a National Institutes of Health (NIH) SBIR Phase II grant to complete a double-blinded, multi-centered, randomized controlled trial (RCT) to demonstrate Ancora-SB superiority over current standards of care and assess the potential to expand indications for use. 

$8.5 Million in Advanced Industries Awards Fuel 32 Colorado Start-Ups, including Aspero Medical's advancement of a novel intraoperative balloon overtube designed to enable complete colonoscopies the first time.

The invention (US Patent No. 11,089,944) covers medical devices that improve anchoring consistency inside the body with textured inflatable balloons.

Animal clinical study finds no histopathological difference between smooth silicone balloon and Aspero's balloon with Pillar technology.  Dr. Steven Edmundowicz, Chief Clinical Officer, is joined by Dr. John Vargo (Cleveland Clinic) and Dr. Andrew Ross (Virginia Mason) on Aspero's Clinical Advisory Board.

Startup company improving endoscopy procedures with their micro-textured balloon technology continues to further develop product line.

From Boulder to the Bay: Alumni investors connect with university startups at Silicon Valley summit. 

$6.1 Million Advanced Industries Awards Fuel 27 Colorado Start-Ups.

The Innosphere Fund announces their investment in Boulder-based start-up company, Aspero Medical Corporation, a company with unique intellectual property for endoscopy procedures that was developed at the University of Colorado.

Creative Destruction Lab supports the commercialization of early stage companies. Working with CDL-Vancouver, Aspero Medical will continue to enable Third-Space Endoscopy and advance flexible endoscopy intervention.

Twenty-one finalists have been named for the 2021 IQ Awards, honoring the “Innovation Quotient” among Boulder Valley and Northern Colorado companies.

Aspero Medical selected as one of 30 innovative startups to pitch at the Innovation Funders Showcase during the Angel Capital Association's 2021 Summit of Angel Investing.

Gastrointestinal endoscopy focused startup company to expand development effort for novel endoscopic single balloon overtube product line.

Aspero Medical selected to present at MedTech Innovator 2020: Los Angeles Pitch Event in coordination with the 8th Annual UCLA MedTech Partnering Conference.

Aspero Medical selected to present at the Rocky Mountain Life Science Investor & Partnering Conference. 

Venture Partners' flagship Research-to-Market program helps innovators create go-to-market strategies for technologies.